![Michael McCall](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael McCall
Director/Board Member at Select Therapeutics, Inc.
Michael McCall active positions
Companies | Position | Start | End |
---|---|---|---|
Select Therapeutics, Inc.
![]() Select Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Select Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is focused on the development of cell based therapeutics production. The company was founded by Clifford A. Lingwood in January 1997 and is headquartered in Brookline, MA. | Director/Board Member | 2010-02-21 | - |
Independent Dir/Board Member | 2000-12-31 | - | |
Cytomatrix
![]() Cytomatrix Miscellaneous Commercial ServicesCommercial Services Part of Cordlife Group Ltd., Cytomatrix is a company that researches, develops, and commercializes novel cell growth systems for hematopoietic (blood) stem cells. The company is based in Woburn, MA. The company was founded by Mark Jerome Pykett. Cytomatrix was acquired by Cordlife Group Ltd. on April 30, 2003 for $11 million. | Director/Board Member | 2010-02-21 | - |
Career history of Michael McCall
Statistics
International
United States | 3 |
Operational
Director/Board Member | 2 |
Independent Dir/Board Member | 1 |
Sectoral
Health Technology | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Select Therapeutics, Inc.
![]() Select Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Select Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is focused on the development of cell based therapeutics production. The company was founded by Clifford A. Lingwood in January 1997 and is headquartered in Brookline, MA. | Health Technology |
Cytomatrix
![]() Cytomatrix Miscellaneous Commercial ServicesCommercial Services Part of Cordlife Group Ltd., Cytomatrix is a company that researches, develops, and commercializes novel cell growth systems for hematopoietic (blood) stem cells. The company is based in Woburn, MA. The company was founded by Mark Jerome Pykett. Cytomatrix was acquired by Cordlife Group Ltd. on April 30, 2003 for $11 million. | Commercial Services |
- Stock Market
- Insiders
- Michael McCall
- Experience